Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Biologicals : Journal of the International Association of Biological Standardization|August 13, 2010
Meeting report on protein particles and immunogenicity of therapeutic proteins: filling in the gaps in risk evaluation and mitigationJohn Carpenter, Barry Cherney, Anthony Lubinecki, et al.
Cellular and Molecular Life Sciences : CMLS|August 30, 2024
Submicron immunoglobulin particles exhibit FcγRII-dependent toxicity linked to autophagy in TNFα-stimulated endothelial cellsWanida C Hollis, Sehrish Farooq, M Reza Khoshi, et al.
Journal of Extracellular Vesicles|May 7, 2016
Characterization of procoagulant extracellular vesicles and platelet membrane disintegration in DMSO-cryopreserved plateletsTseday Z Tegegn, Silvia H De Paoli, Martina Orecna, et al.
Transfusion|December 16, 2024
Effect of concurrent pathogen reduction (amotosalen/UVA) and gamma/x-ray irradiation on biochemical characteristics of apheresis platelets in additive solutionM Reza Khoshi, Andrey Skripchenko, Robel Seifu, et al.
Biomaterials|May 17, 2014
The effect of protein corona composition on the interaction of carbon nanotubes with human blood plateletsSilvia H De Paoli, Lukas L Diduch, Tseday Z Tegegn, et al.
JCI Insight|November 3, 2018
Hemoglobin oxidation-dependent reactions promote interactions with band 3 and oxidative changes in sickle cell-derived microparticlesSirsendu Jana, Michael Brad Strader, Fantao Meng, et al.
Cellular and Molecular Life Sciences : CMLS|February 11, 2018
Dissecting the biochemical architecture and morphological release pathways of the human platelet extracellular vesiculomeSilvia H De Paoli, Tseday Z Tegegn, Oumsalama K Elhelu, et al.
Transfusion|November 14, 2025
Effects of an amustaline (S-303)/glutathione pathogen reduction system on the in vitro quality of plasma and platelets in treated whole bloodM Reza Khoshi, Ayantu Jinfessa, Anais Pongerard, et al.
Journal of Pharmaceutical Sciences|February 18, 2016
Subvisible Particle Content, Formulation, and Dose of an Erythropoietin Peptide Mimetic Product Are Associated With Severe Adverse Postmarketing EventsJoseph Kotarek, Christine Stuart, Silvia H De Paoli, et al.
Pageof 3